Search:
 
BioEnterprise
Recent News

» Clayton Dubilier & Goldman Sachs to Acquire Edgepark Medical for $850 Million
» Great Lakes Pharmaceuticals raises $3.1 Million
» AxioMed Raises $14.5 Million
» Syncro Raises Additional $800,000
» Factory Jobs Return, but Employers Find Skills Shortage
» Two Healthcare Companies Announce Major Expansions
» Ohioans vote for their futures, extend Third Frontier program



Commercialized Products & Services


Syncro Blue Tube
One of the many health care innovations brought to market by client companies.
» View More




Exit Companies



Since 2002, 21 Cleveland-area health care companies have had successful exits.

» View More




Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the health care industry.
» View More
Companies > Clinical
print
Freedom Meditech is developing two products for commercialization in the diabetes space. Closest to market is an ophthalmic instrument which screens for diabetes for utilization by Opthamologists and Optometrists. The other product is a non-invasive method for diabetics to monitor their glucose levels daily. It makes the measurement painlessly and accurately from the eye using a technology known as ocular polarimetry.

Funders:
JumpStart, Angels

 
Copyright © 2010 BioEnterprise   | Home | Disclaimer | Sitemap | Contact Us BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999